Hostile health-care environment could increase migrants' risk of HIV and prevent access to vital services

Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom.

HIV research & clinical practice·2026

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial.

Nature medicine·2026

Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021-2024.

Infectious diseases and therapy·2026

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

The New England journal of medicine·2026

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Open forum infectious diseases·2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

The present and future of HIV and viral hepatitis co-infection.

The lancet. HIV·2026

Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study.

The lancet. HIV·2026

Epidemiological trends of HIV among individuals aged 15-54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study.

The lancet. HIV·2026

Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries.

The lancet. HIV·2026

Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study.

The lancet. HIV·2026

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.

The lancet. HIV·2026

Incidence of Intensive Care Unit Delirium After Heart Surgery: A Feasibility Study of a Forest Environment Intervention.

Nursing in critical care·2026

Cell therapies: are we doing enough to protect patients and address the barriers to patient access?

Cytotherapy·2026

Unsafe firearm storage among family caregivers of older persons living with dementia.

PloS one·2026

The hidden burden of data entry: How administrative demands rob rural patients of bedside care.

Tropical doctor·2026

Defending synthetic DNA orders against intra-order splitting-based obfuscation.

Nature communications·2026

While You Were Sleeping: Public Confidence in Rapid-Onset Hazard Warning Reception During Overnight Hours.

Disaster medicine and public health preparedness·2026

Hostile health-care environment could increase migrants' risk of HIV and prevent access to vital services

Related Experiment Videos

Related Concept Videos

Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom.

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial.

Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021-2024.

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

The present and future of HIV and viral hepatitis co-infection.

Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study.

Epidemiological trends of HIV among individuals aged 15-54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study.

Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries.

Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study.

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.

Incidence of Intensive Care Unit Delirium After Heart Surgery: A Feasibility Study of a Forest Environment Intervention.

Cell therapies: are we doing enough to protect patients and address the barriers to patient access?

Unsafe firearm storage among family caregivers of older persons living with dementia.

The hidden burden of data entry: How administrative demands rob rural patients of bedside care.

Defending synthetic DNA orders against intra-order splitting-based obfuscation.

While You Were Sleeping: Public Confidence in Rapid-Onset Hazard Warning Reception During Overnight Hours.

Hostile health-care environment could increase migrants' risk of HIV and prevent access to vital services

Related Experiment Videos

Related Concept Videos

Related Articles